HOME >> BIOLOGY >> NEWS
UT Southwestern research halts narcolepsy symptoms

DALLAS March 15, 2004 Researchers at UT Southwestern Medical Center at Dallas have discovered a potentially new avenue for treating human narcolepsy, and the work may also lead to more effective ways for insomniacs to boost their wakefulness during the daytime.

Artificially reintroducing a brain chemical called orexin into mice that lack the ability to produce the chemical on their own rids the mice of their narcolepsy symptoms, UT Southwestern researchers have discovered. Their work appears in an upcoming issue of the Proceedings of the National Academy of Sciences and is currently available online.

The genetically engineered mice used lacked a particular type of nerve cell in the brain that produces orexin. Most researchers believe that in humans, a lack of or deficiency in orexin causes narcolepsy, a rare disease in which people uncontrollably fall asleep, have excessive daytime sleepiness, and experience sudden muscle weakness called cataplexy.

"Assuming that narcoleptic humans are like these mice, which is a very plausible assumption, our experiments provide a strong proof of concept that introducing into the brain a molecule that mimics the effect of orexin will be the fundamental cure for human narcolepsy," said Dr. Masashi Yanagisawa, professor of molecular genetics and the paper's senior author.

Orexins are small chains of molecules made by nerve cells, or neurons, in the region of the brain called the hypothalamus. In 2001 Dr. Yanagisawa, an investigator in the Howard Hughes Medical Institute at UT Southwestern, and his research group were the first to genetically engineer knockout mice that lacked orexin-producing brain cells. Without these neurons, the mice did not wake up to feed as normal mice did, and they also experienced cataplectic arrests. "We believe these mice represent the closest model of human narcolepsy," Dr. Yanagisawa said.

In their latest research, Dr. Yanagisawa and his colleagues "rescued" the
'"/>

Contact: Amanda Siegfried
amanda.siegfried@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
15-Mar-2004


Page: 1 2 3

Related biology news :

1. UT Southwestern receives $1.78 million grant for obesity research as part of NIH Roadmap initiative
2. UT Southwestern biochemist honored with NIH Directors Pioneer Award
3. RSV can increase the risk of asthma, UT Southwestern researchers find
4. Searle Scholars program awards $240,000 to UT Southwestern researcher
5. Two molecules work together to aid transport of immune cells, UT Southwestern researchers find
6. Biochemist becomes 15th UT Southwestern faculty member serving on National Academy of Sciences
7. UT Southwestern researchers reveal mechanisms of smooth-muscle contraction
8. Fetal lungs provide a signal initiating labor, UT Southwestern researchers find
9. UT Southwestern researchers cite recent advances in underlying causes of rare body-fat disorders
10. UT Southwestern researchers discover link that could aid in treatment of kidney cyst diseases
11. UT Southwestern researchers identify gene as essential for vascular smooth muscle development

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/30/2019)... ... September 30, 2019 , ... Foresight Institute, a ... other transformative technologies, announced the winners for the 2019 Foresight Institute Feynman Prizes. ... Theory in nanotechnology/molecular manufacturing. , Established in 1993 and named in honor of ...
(Date:9/30/2019)... DURHAM, N.C. (PRWEB) , ... September 30, 2019 , ... ... therapy and an accepted model for studying the development and diseases of the human ... or potential activities of the progeny heart muscle cells to be clearly and easily ...
(Date:9/30/2019)... ALTO, Calif. (PRWEB) , ... ... ... Institute, a leading think tank, research, and public interest organization focused on ... prestigious Distinguished Student Prize. , The Award recognizes the College graduate or ...
Breaking Biology News(10 mins):
(Date:9/30/2019)... ... September 30, 2019 , ... The September 2019 ... Corporation , is now available online on the company’s global website. The Bridge ... X-ray diffraction, fluorescence and imaging, and presents articles, scientific papers and news reports. ...
(Date:9/24/2019)... POWAY, Calif. (PRWEB) , ... September 24, 2019 ... ... human adipose-derived stem cell company, has completed training and site qualification for clinical ... the process of recruitment and screening of potential clinical trial participants. , Clinical ...
(Date:9/17/2019)... SOMERSET, N.J. (PRWEB) , ... September 17, 2019 ... ... today announced that Julie Delaney, Director, Project and Clinical Supplies Management, Asia Pacific ... at the One Farrer Hotel, Singapore, on Sept. 25-26, 2019. , On Thursday, ...
(Date:9/17/2019)... ... 2019 , ... When a lot of researchers think of Visikol, they think ... characterization of tissues through the use of confocal and light sheet microscopy. However, over ... cell culture focused contract research organization and today offers 3D tissue imaging ...
Breaking Biology Technology:
Cached News: